A new floating droplet electricity generator is redefining how rain can be harvested as a clean power source by using water itself as both structural support and an electrode. This nature-integrated ...
Those who believe in Elon Musk are convinced both by his vision to go where no one has ventured before and his ability to pay for it—what some call the „Elon backstop”. Mr M ...
Members-only New York social club Core accused the embattled developer Michael Shvo of fraud. But it couldn’t convince the court. A New York judge dismissed several of Core Club’s legal complaints ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
Space The AMOC moves closer to collapse, scientists create artificial neurons, the "Iliad" is found inside and Egyptian mummy, and researchers search for treatments for brain-eating amoebas Artificial ...
With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...
Sora could soon get more accessible in ChatGPT, potentially leading to a new flood of deepfakes from the video generator. Sora could soon get more accessible in ChatGPT, potentially leading to a new ...
Two major Bitcoin miners, MARA Holdings and Core Scientific, are shifting strategies to sell portions of their bitcoin holdings as they pivot toward AI and high-performance computing operations. For ...
A new report says that Apple will replace Core ML with a modernized Core AI framework at WWDC, helping developers better leverage modern AI capabilities with their apps in iOS 27. Mark Gurman reports ...
Apple is expected to push its Gemini-trained Apple Foundation Models and new chatbot-like Siri functions during WWDC, but Core ML could also see an update to Core AI to emphasize the priority shift.
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...